Stock listing

NASDAQ:EVAX Evaxion A/S Stock

Follow Evaxion A/S into a list and get an email when it puts out news.

Share price · NASDAQ:EVAX

$2.97 USD +0.01 (+0.3%)

Close on Nov 4, 2026

Past year -47.0% · daily closes, Nov 4, 2025 – Nov 4, 2026, adjusted for splits
Day range
$2.97 – $3.16 USDNov 4, 2026
Volume
27,622 sharesNov 4, 2026
Market cap
$26.79M USDAt the close on Nov 4, 2026 · price × 9.02M shares outstanding
52-week range
$2.72 – $6.92 USDLowest and highest trades, Nov 5, 2025 – Nov 4, 2026
Traded on an average day
$740,229 USDMedian day 41,923 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Evaxion A/S logo

Daily closes

Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:EVAX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.97+0.01+0.3%$3.05$3.16$2.9727,622
$2.96+0.04+1.4%$3.19$3.19$2.9328,722
$2.92-0.01-0.3%$2.93$3.05$2.9034,578
$2.93-0.15-4.9%$3.11$3.155$2.8946,197
$3.08-0.03-1.0%$3.10$3.17$3.0040,545
$3.11+0.07+2.3%$3.01$3.19$3.0151,036
$3.04-0.04-1.3%$3.09$3.235$2.9375,714
$3.08-0.68-18.1%$3.78$3.78$2.96219,415
$3.76+0.05+1.3%$3.96$4.00$3.652161,649
$3.710.000.0%$3.73$3.75$3.55107,600
$3.71-0.34-8.4%$4.16$4.50$3.65325,500
$4.05+0.72+21.6%$3.30$4.117$3.22530,200
$3.33+0.50+17.7%$3.11$3.60$2.972467,800
$2.83+0.03+1.1%$2.85$2.919$2.7974,500
$2.800.000.0%$2.80$2.90$2.7935,100
$2.80+0.04+1.4%$2.76$2.83$2.75350,400
$2.76-0.24-8.0%$2.98$2.99$2.72133,800
$3.00-0.07-2.3%$3.07$3.23$2.9960,800
$3.07+0.02+0.7%$3.03$3.13$3.0227,900
$3.05-0.11-3.5%$3.18$3.23$3.0264,000
$3.160.000.0%$3.16$3.25$3.1121,700
$3.16+0.01+0.3%$3.24$3.25$3.1235,900
$3.15-0.05-1.6%$3.20$3.24$3.1438,200
$3.20+0.02+0.6%$3.23$3.275$3.15633,900
$3.18-0.10-3.0%$3.25$3.29$3.1338,100
$3.28+0.01+0.3%$3.35$3.35$3.24218,000
$3.27+0.03+0.9%$3.20$3.31$3.2038,100
$3.24-0.10-3.0%$3.34$3.35$3.1955,700
$3.34+0.08+2.5%$3.30$3.35$3.2445,000
$3.26-0.02-0.6%$3.30$3.35$3.2536,900
$3.28+0.01+0.3%$3.33$3.35$3.24235,200
$3.27+0.06+1.9%$3.18$3.31$3.1832,300
$3.21-0.06-1.8%$3.24$3.25$3.1736,800
$3.27+0.05+1.6%$3.22$3.33$3.1643,300
$3.22+0.19+6.3%$3.10$3.25$3.0553,300
$3.03-0.01-0.3%$3.03$3.24$3.0073,900
$3.04-0.03-1.0%$3.12$3.15$3.0011,000
$3.07-0.06-1.9%$3.17$3.17$3.0721,900
$3.13+0.03+1.0%$3.17$3.20$3.1029,800
$3.10-0.19-5.8%$3.29$3.29$3.0587,100
$3.29+0.12+3.8%$3.22$3.33$3.2161,400
$3.17+0.05+1.6%$3.12$3.305$3.1063,800
$3.12+0.04+1.3%$3.12$3.16$3.0638,300
$3.08+0.01+0.3%$3.10$3.15$3.06739,600
$3.07+0.09+3.0%$3.00$3.191$2.9959,500
$2.98-0.02-0.7%$2.98$3.04$2.9263,000
$3.00-0.01-0.3%$3.07$3.07$2.90102,000
$3.01-0.14-4.4%$3.15$3.16$3.01122,600
$3.15-0.09-2.8%$3.29$3.30$3.1473,900
$3.24-0.11-3.3%$3.32$3.40$3.18112,100
$3.35-0.05-1.5%$3.41$3.55$3.34148,800
$3.40+0.09+2.7%$3.33$3.46$3.17182,300
$3.31+0.03+0.9%$3.37$3.45$3.12540,100
$3.28+0.13+4.1%$3.40$3.64$2.953,595,100
$3.150.000.0%$3.03$3.37$2.836,361,800
$3.15+0.02+0.6%$3.09$3.177$3.0011,000
$3.13-0.21-6.3%$3.35$3.40$3.05818,100
$3.34+0.129+4.0%$3.29$3.34$3.1619,800
$3.211+0.141+4.6%$3.10$3.38$3.1012,600
$3.07+0.01+0.3%$3.005$3.16$2.9721,500
$3.06+0.01+0.3%$3.07$3.15$2.9716,900
$3.05-0.05-1.6%$3.10$3.32$3.0335,100
$3.10+0.105+3.5%$3.10$3.10$2.978,000
$2.995+0.015+0.5%$2.99$3.05$2.946,500
$2.98+0.03+1.0%$2.90$3.04$2.909,700
$2.95+0.16+5.7%$2.801$3.00$2.8010,900
Ticker
NASDAQ:EVAX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Evaxion (NASDAQ:EVAX) Q2 2026 Earnings Call

    Thu, Aug 20, 2026 · 8:30 AM ET

    Watch Transcript

  • Evaxion (NASDAQ:EVAX) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:30 AM ET

    Watch Transcript

  • Evaxion (NASDAQ:EVAX) Q4 2025 Earnings Call

    Fri, Mar 06, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Nov 4, 2026

Closed $2.97 (+0.3%) on Nov 4, 2026

Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting

Nov 3, 2026

Closed $2.96 (+1.4%) on Nov 3, 2026

Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

Oct 30, 2026

Closed $2.93 (-4.9%) on Oct 30, 2026

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

Oct 23, 2026

Closed $3.76 (+1.3%) on Oct 23, 2026

All Evaxion A/S news

Decks

Evaxion A/S on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 5 in all · newest Nov 4, 2026 · oldest 2026
Calls
16 calls with a replay · 16 with a transcript · latest Aug 20, 2026
Decks
18 decks · latest Oct 1, 2026

Log in to ask 6ix AI your own questions about Evaxion A/S.